Health Technology Holding (HTH)
Pre-Seed–Series B · 1 people tracked
Investment thesis
Hands-on early-stage life‑science investor and advisor offering deep, science-driven due diligence (PoC, MoA, animal models, KOL/clinician interviews) and access to pharma, corporate partnerships and stakeholder networks.
Team · 1 people
from public directories
Frequently asked questions
- What stage does Health Technology Holding (HTH) invest at?
- Health Technology Holding (HTH) invests at the Pre-Seed, Seed, Series A, Series B stages.
- What is Health Technology Holding (HTH)'s typical check size?
- Health Technology Holding (HTH) typically writes checks of $500K – $1M.
- What sectors does Health Technology Holding (HTH) focus on?
- Health Technology Holding (HTH) focuses on AI & Machine Learning, Biotech, Healthtech, Medical Devices.
- Does Health Technology Holding (HTH) lead rounds?
- Health Technology Holding (HTH) typically participates in rounds rather than leading them.
Similar investors
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
Medical Excellence Capital (MEC) is a venture firm focused on precision health and life sciences, pairing investment professionals and operators with a proprietary national medical network platform.
Ambix is a healthcare-focused investment firm that provides funding, strategy, and hands-on support to companies developing medical tools and devices, biochemistry-based technologies, digital health applications, and other novel healthcare solutions. It invests across all stages and also builds companies itself.
IDG Capital is a multi-strategy investment platform founded in 1993 that supports entrepreneurs across the full business lifecycle, bridging East and West with a global presence and over 300 professionals.